Therapeutic Area | MeSH |
---|---|
infections | D007239 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
NYDRAZID | Bristol Myers Squibb | N-008392 DISCN | 1982-01-01 | 1 products |
ISONIAZID | Epic Pharma | N-008678 DISCN | 1982-01-01 | 2 products, RLD |
ISONIAZID | Eli Lilly | N-008499 DISCN | 1982-01-01 | 2 products |
ISONIAZID | Panray Corporation | N-008428 DISCN | 1982-01-01 | 3 products |
RIMIFON | Roche | N-008420 DISCN | 1982-01-01 | 3 products |
NYDRAZID | Sandoz | N-008662 DISCN | 1982-01-01 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
albuterol sulfate inhalation solution | ANDA | 2024-12-17 |
albuterol sulfate inhalation solution, 0.5% | ANDA | 2025-03-24 |
ammonia | unapproved drug other | 2021-09-02 |
ammonia inhalant | unapproved drug other | 2020-04-27 |
ammonia inhalants | unapproved drug other | 2024-10-28 |
amoray premium vaporizing inhaler | OTC monograph final | 2016-03-31 |
arformoterol tartrate inhalation | ANDA | 2023-01-24 |
arformoterol tartrate inhalation solution | ANDA | 2025-02-11 |
bardown smelling salts | unapproved drug other | 2025-04-16 |
berinert | Biologic Licensing Application | 2009-11-10 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Tuberculosis | D014376 | EFO_0000774 | A15-A19 | 31 | 94 | 74 | 39 | 74 | 285 |
Pulmonary tuberculosis | D014397 | EFO_1000049 | A15 | 7 | 43 | 24 | 8 | 12 | 83 |
Hiv infections | D015658 | EFO_0000764 | B20 | 5 | 14 | 17 | 10 | 16 | 57 |
Latent tuberculosis | D055985 | — | Z22.7 | 9 | 5 | 16 | 10 | 8 | 44 |
Infections | D007239 | EFO_0000544 | — | 2 | 7 | 14 | 4 | 6 | 31 |
Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | 1 | 4 | 9 | 2 | 8 | 23 |
Multidrug-resistant tuberculosis | D018088 | EFO_0007381 | — | 1 | 5 | 9 | 2 | 8 | 22 |
Angioedema | D000799 | EFO_0005532 | T78.3 | 1 | 7 | 9 | 3 | 4 | 21 |
Hereditary angioedemas | D054179 | EFO_0004131 | — | 1 | 7 | 8 | 3 | 4 | 20 |
Hiv | D006678 | — | O98.7 | 3 | 3 | 6 | 1 | 5 | 17 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Meningeal tuberculosis | D014390 | — | A17.0 | 1 | 7 | 3 | — | 2 | 11 |
Meningitis | D008581 | EFO_0000584 | G03 | — | 6 | 3 | — | 2 | 10 |
Asthma | D001249 | EFO_0000270 | J45 | 1 | 1 | 6 | — | — | 8 |
Hypersensitivity | D006967 | EFO_0003785 | T78.40 | — | 4 | 2 | — | — | 5 |
Uveitis | D014605 | EFO_1001231 | H20.9 | — | 1 | 1 | — | 1 | 3 |
Extensively drug-resistant tuberculosis | D054908 | — | — | — | 1 | 2 | — | 1 | 3 |
Hemophilia a | D006467 | EFO_0007267 | D66 | — | — | 1 | — | 1 | 2 |
Silicosis | D012829 | EFO_0007485 | J62 | — | — | 1 | — | 1 | 2 |
Malnutrition | D044342 | EFO_0008572 | E40-E46 | — | — | 1 | — | 1 | 2 |
Pneumonia | D011014 | EFO_0003106 | J18 | — | 1 | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Respiratory tract infections | D012141 | — | J06.9 | 1 | 1 | — | — | 1 | 2 |
Wounds and injuries | D014947 | — | T14.8 | — | 1 | — | — | 1 | 2 |
Paroxysmal hemoglobinuria | D006457 | Orphanet_447 | D59.12 | — | 2 | — | — | — | 2 |
Hemoglobinuria | D006456 | — | R82.3 | — | 2 | — | — | — | 2 |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 1 | 1 | — | — | — | 1 |
Malaria | D008288 | EFO_0001068 | B54 | — | 1 | — | — | — | 1 |
Traumatic brain injuries | D000070642 | — | S06 | — | 1 | — | — | — | 1 |
Craniocerebral trauma | D006259 | — | S00 | — | 1 | — | — | — | 1 |
Brain injuries | D001930 | — | S06.9 | — | 1 | — | — | — | 1 |
Graft rejection | D006084 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 5 | — | — | — | 1 | 6 |
Lung diseases | D008171 | EFO_0003818 | J98.4 | 1 | — | — | — | 1 | 2 |
Osteomyelitis | D010019 | EFO_0003102 | M86 | 1 | — | — | — | — | 1 |
Drug interactions | D004347 | — | — | 1 | — | — | — | — | 1 |
Melanoma | D008545 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Kidney transplantation | D016030 | — | — | — | — | — | — | 3 | 3 |
Body weight | D001835 | EFO_0004338 | — | — | — | — | — | 2 | 2 |
Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 2 | 2 |
Covid-19 | D000086382 | — | U07.1 | — | — | — | — | 2 | 2 |
Opioid-related disorders | D009293 | EFO_0005611 | F11 | — | — | — | — | 1 | 1 |
Addictive behavior | D016739 | EFO_0004347 | — | — | — | — | — | 1 | 1 |
Birth weight | D001724 | EFO_0004344 | — | — | — | — | — | 1 | 1 |
Acute cholecystitis | D041881 | EFO_1001289 | K81.0 | — | — | — | — | 1 | 1 |
Cholecystitis | D002764 | — | K81 | — | — | — | — | 1 | 1 |
Acalculous cholecystitis | D042101 | EFO_1000790 | — | — | — | — | — | 1 | 1 |
Drug common name | Isoniazid |
INN | isoniazid |
Description | Isoniazide is a carbohydrazide obtained by formal condensation between pyridine-4-carboxylic acid and hydrazine. It has a role as an antitubercular agent and a drug allergen. It is functionally related to an isonicotinic acid. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | NNC(=O)c1ccncc1 |
PDB | — |
CAS-ID | 54-85-3 |
RxCUI | — |
ChEMBL ID | CHEMBL64 |
ChEBI ID | 6030 |
PubChem CID | 3767 |
DrugBank | DB00951 |
UNII ID | V83O1VOZ8L (ChemIDplus, GSRS) |